MMA Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
MMA Asset Management's RPRX Position: Q3 2026 in Review
MMA Asset Management reduced its Royalty Pharma (RPRX) stake by 43% in Q3 2026, selling an estimated $313K and leaving 7,094 shares worth $414K. The position accounts for 0.13% of the portfolio, ranked #140.
MMA Asset Management first reported a position in RPRX in Q2 2025 and has held it in 6 quarters since. The position peaked at $695K in Q2 2026. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- MMA Asset Management held 7,094 shares of Royalty Pharma worth $414K as of Q3 2026.
- MMA Asset Management sold 5,304 Royalty Pharma shares in Q3 2026, an estimated $313K.
- Royalty Pharma made up 0.13% of MMA Asset Management's portfolio in Q3 2026, its #140 holding.
- MMA Asset Management first reported a position in Royalty Pharma in Q2 2025 and has held it in 6 quarters since.
- MMA Asset Management's Royalty Pharma position peaked at $695K in Q2 2026.
- 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on MMA Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.